Medical News

RSS

Nuvera announces results of blinded study on breast cancer assay for taxane chemotherapy response

Nuvera Biosciences, a molecular diagnostics company that develops gene-based diagnostic assays for personalized medicine in cancer, announced the results of a blinded validation study on its breast cancer assay for taxane chemotherapy response.

4 Jun 2011

NIH approves BioTime's two human embryonic stem cell lines for clinical use

BioTime, Inc., a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that two human embryonic stem (hES) cell lines, ESI-014 and ESI-017, developed by a BioTime subsidiary have been approved by the National Institutes of Health (NIH) for inclusion in the NIH Human Embryonic Stem Cell Registry.

4 Jun 2011

News highlights: Study finds reform didn't slow ER visits in Mass.; 2 ACOs take shape in Calif.; Md. hospitals report problems

Health care reform in Massachusetts only had a small impact on the number of trips residents took to the emergency room, according to a new study.

4 Jun 2011

Physiotherapy Associates inaugurates new Cedar Park facility

Physiotherapy Associates, the nation's foremost provider of outpatient rehabilitation services, recently opened a new physical therapy clinic in Cedar Park, TX. The Strickland Physical Therapy Associates clinic offers a comprehensive range of physical therapy services, including: manual therapy, foot and ankle, neck and back, and sports medicine.

4 Jun 2011

Walgreen acquires drugstore.com

Walgreen Co. today announced that it has completed its acquisition of drugstore.com. The transaction includes all websites directly owned and operated by drugstore.com, as well as its corporate office and customer service and distribution center operations.

3 Jun 2011

U.S. should delay and reform Pakistan aid, report says

U.S. aid efforts in Pakistan have become "muddled" and should be delayed until reforms are implemented, a report (.pdf) compiled by a Center for Global Development (CGD) task force, said on Wednesday, Agence France-Presse reports (Tandon, 6/1).

3 Jun 2011

Cancer vaccine shows improved response rate in patients

A vaccine for one of the most lethal cancers, advanced melanoma, has improved response rate and progression-free survival for patients when combined with the immunotherapy drug Interleukin-2, according to research led by scientists from The University of Texas MD Anderson Cancer Center and Indiana University Health Goshen Center for Cancer Care.

3 Jun 2011

National Cancer Survivors Day to be held on June 5th 2011

The 24th National Cancer Survivors Day will be held on June 5th this year. "This annual event is a national recognition that we have made significant progress in the fight against cancer," said Dr. Patricia Robinson, director of Loyola University Health System's Cancer Survivorship Program. Robinson sees cancer survivors at Loyola's main campus in Maywood and at the Loyola Center for Health at Wheaton.

3 Jun 2011

Delayed treatment could prove effective in certain medical conditions

In today's fast-paced world, waiting — whether it's at the doctor's office, in line at the grocery store or for an Internet connection — is rarely considered a good thing.

3 Jun 2011

Kronos to provide integrated workforce management solution to Beaver Dam Community Hospitals

Kronos Incorporated today announced that Beaver Dam Community Hospitals, Inc. (BDCH), an independent, non-profit healthcare organization serving the regions of Dodge, Columbia, and Fond du Lac Counties in Wisconsin, has selected Kronos® to provide an integrated workforce management solution comprised of time and attendance, absence management, HR/payroll, and selection and hiring.

3 Jun 2011

Bexarotene and erlotinib drugs effective in treating advanced lung cancer

Scientists have identified a drug combination, when used in advanced lung cancer patients, shows a survival advantage in patients who no longer respond to existing therapies.

3 Jun 2011

Candidate Romney on differences in 'Romneycare' And 'Obamacare'

Former Mass. Gov. Mitt Romney, who now is seeking the GOP presidential nomination, continues to pledge to repeal the sweeping health measure signed into law by President Barack Obama. Meanwhile, fact-checkers focus on how different the federal health law is from the state reforms Romney signed into law five years ago.

3 Jun 2011

C-Path forms ePRO Consortium

Critical Path Institute has established the Electronic Patient-Reported Outcome (ePRO) Consortium comprising five member firms that provide innovative electronic data collection technologies for capturing patient-reported outcome (PRO) endpoints in clinical trials.

3 Jun 2011

AxoGen, LecTec sign merger agreement

LecTec Corporation announced today that on May 31, 2011 it entered into an Agreement and Plan of Merger ("Merger Agreement") with AxoGen Corporation, d/b/a AxoGen Inc., a privately held company focused on developing and commercializing medical products for the repair of peripheral nerve injuries.

3 Jun 2011

Mimicry allows bacteria to evade host's defense responses

Deadly bacteria may be evolving antibiotic resistance by mimicking human proteins, according to a new study by the Translational Genomics Research Institute (TGen).

3 Jun 2011

Message is key in debate over Medicaid block grant plans

Some congressional Democrats are concerned that Medicaid will become even more of a target for funding cuts and, as a result, are rallying the troops.

3 Jun 2011

Highest percentage of readmissions occur in 45 to 64 age group

In 2008 nearly 12 percent of hospital stays were readmissions within 30 days of a previous stay, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

3 Jun 2011

Technology, expert training and real-time feedback improves Hepatitis C outcomes

Widely-available technology, expert training and real-time feedback helped ensure that patients treated for Hepatitis C in local communities did as well as patients treated at a university-based medical center, results of a new study funded by HHS' Agency for Healthcare Research and Quality show. The study is published in the June 2 online issue of the New England Journal of Medicine and in the June 9 print edition.

3 Jun 2011

Preclinical study: Combination therapy of SPX-106 and D-tagatose reduces triglycerides and cholesterol

Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its drug candidate, SPX-106, achieved statistically significant reductions in triglycerides and cholesterol when administered in combination with D-tagatose for nine weeks to genetically engineered mice prone to dyslipidemia.

3 Jun 2011